- Home
- SIGA
as 12-20-2024 2:42pm EST
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 551.0M | IPO Year: | 1997 |
| Target Price: | N/A | AVG Volume (30 days): | 567.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | 1.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.26 - $12.83 | Next Earning Date: | 11-07-2024 |
| Revenue: | $173,731,386 | Revenue Growth: | 399.31% |
| Revenue Growth (this year): | 16.79% | Revenue Growth (next year): | 15.08% |
Latest SIGA Technologies Inc. News
SIGA Breaking Stock News: Dive into SIGA Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Undiscovered Gems In The United States To Explore December 2024
Zacks
11 days ago
Is Siga Technologies (SIGA) Stock Outpacing Its Medical Peers This Year?
GlobeNewswire
12 days ago
Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced
Zacks
13 days ago
Should Value Investors Buy Siga Technologies (SIGA) Stock?
Zacks
17 days ago
Siga Technologies (SIGA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Insider Monkey
22 days ago
Why SIGA Technologies (SIGA) Is One of the Most Profitable Pharmaceutical Stocks Right Now?
Zacks
a month ago
Are Investors Undervaluing Siga Technologies (SIGA) Right Now?
Simply Wall St.
a month ago
Impressive Earnings May Not Tell The Whole Story For SIGA Technologies (NASDAQ:SIGA)
Compare SIGA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SIGA SIGA Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.